Skip to main content
Premium Trial:

Request an Annual Quote

Pittsburgh Business Backer Invests $150K in siRNA Chip Startup Falcon Genomics

NEW YORK (GenomeWeb News) - The Pittsburgh Life Sciences Greenhouse, a public-private partnership that corrals start-up investment capital for Pittsburgh-area life sciences businesses, said Tuesday it will fuel a fledgling siRNA-focused business with $150,000, and will dish out $200,000 between two other biotech companies.
 
PLSG has invested $150,000 in Falcon Genomics to support validation of the company's Cancer BioChip System, which PLSG said is "a high throughput assay system for individualized cancer target identification and validation using silencing RNA."
 
The biochip system will be used to determine which abnormal gene is responsible for uncontrolled cell division that causes tumors to grow, allowing therapies to connect specific silencing agents to certain cancers.
 
PLSG also invested $100,000 each in Celsense, which is developing imaging technology to monitor transplanted cells; and Glucose Sensing Technologies, which is developing a colorimetric sensor for glucose monitoring.